New dates announced: AI and Big Data in Cancer postponed to November 15-17, 2020Read more here
As the spread of COVID-19 continues and the situation is still uncertain, Elsevier has taken the decision to postpone AI and Big Data in Cancer to November 15-17, 2020, in the same venue in Boston, USA.
We will continue to closely monitor developments, taking advice from the WHO, the CDC and other relevant agencies, but as the safety of our customers and colleagues is paramount, we feel it is pertinent to postpone until November.
Any pre-registered delegate will automatically be transferred to the new conference date in November unless you notify us that you will not be able to attend on those dates.
The future of medicine is data-driven and AI-enabled. Artificial intelligence will impact diagnosis, treatment decisions and patient care. Learn from others along the value-chain to understand how to effectively translate technology, data and analytic innovations into clinical practices and patient benefits and find the right partners to move your innovations forward.
Poster Awards: Submit abstracts here.
Join the conversation #AICancer2020
from the insights of leading researchers, clinicians, technologists, entrepreneurs, regulators, and payers
the conversation and network with leaders and innovators across industry, academia, and government
your stay when visiting the Westin Boston Waterfront during the conference
the groundbreaking symposium bridging technological innovation and clinical application
Elsevier seeks to promote and facilitate an open conversation between disparate stakeholders to accelerate the implementation of AI in oncology care.
Get the latest conference updates by signing up to our event newsletter
Have question about the conference or issues with registration
Exhibit with us
To discuss your requirements or to book sponsorship or exhibit space please contact:
Carolina Ulloa Parra
Conference Sponsorship Sales Executive
STM Journals | Elsevier
Radarweg 29 | 1043NX Amsterdam | The Netherlands
T: +31 20 485 2125 | E-mail: email@example.com